Journal of General Internal Medicine

, Volume 14, Issue 7, pp 446-448

When should we delay highly active antiretroviral therapy?

  • David R. BangsbergAffiliated withEpidemiology and Prevention Intervention Center, San Francisco General Hospital
  • , Andrew MossAffiliated withDepartment of Epidemiology and Biostatistics, University of California

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access